Age, pathology and CA-125 are prognostic factors for survival in patients with brain metastases from gynaecological tumours | Zendy

S. Nagtegaal | Zendy; Alexander Hulsbergen | Zendy; E.B.L. van Dorst | Zendy; Vasileios K. Kavouridis | Zendy; Charissa Jessurun | Zendy; Marike L. D. Broekman | Zendy; Timothy R. Smith | Zendy; Joost J.C. Verhoeff | Zendy

Open Access

Age, pathology and CA-125 are prognostic factors for survival in patients with brain metastases from gynaecological tumours

Author(s) -

S. Nagtegaal,

Alexander Hulsbergen,

E.B.L. van Dorst,

Vasileios K. Kavouridis,

Charissa Jessurun,

Marike L. D. Broekman,

Timothy R. Smith,

Joost J.C. Verhoeff

Publication year - 2020

Publication title -

clinical and translational radiation oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.336

H-Index - 15

ISSN - 2405-6308

DOI - 10.1016/j.ctro.2020.05.001

Subject(s) - medicine , cohort , proportional hazards model , oncology , gynecologic oncology , ovary , hazard ratio , survival analysis , incidence (geometry) , malignancy , ovarian carcinoma , ovarian cancer , pathology , cancer , confidence interval , physics , optics

Brain metastases originating from gynaecological tumours are a rare phenomenon, but have an increasing incidence due to better targeted therapies. This study aimed to identify factors that predict survival in these patients, which can be used in creating a robust prognostic tool for shared decision making.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research